Search Results - "Serreau, R"

Refine Results
  1. 1
  2. 2

    Changes in Enoxaparin Pharmacokinetics During Pregnancy and Implications for Antithrombotic Therapeutic Strategy by Lebaudy, C, Hulot, JS, Amoura, Z, Costedoat‐Chalumeau, N, Serreau, R, Ankri, A, Conard, J, Cornet, A, Dommergues, M, Piette, JC, Lechat, P

    Published in Clinical pharmacology and therapeutics (01-09-2008)
    “…Enoxaparin is frequently prescribed for pregnant women who are at high risk for thromboembolic complications. We conducted a population pharmacokinetics study…”
    Get full text
    Journal Article
  3. 3

    Guidelines for multivitamin administration in fortified human milk prepared for preterm infants by Rigourd, V, Dridi Brahim, I, Smii, S, Razafimahefa, H, Quetin, F, Leroy, E, Pichon, C, Giuseppi, A, Berthier, L, Pommeret, B, Serreau, R

    “…To reach nutritional standards, human milk has to have 2g/dL of protein. In 2013, Lafeber stated that when human milk is fortified up to 2g/dL, it may increase…”
    Get full text
    Journal Article
  4. 4

    Population Pharmacokinetics of Ciprofloxacin in Pediatric and Adolescent Patients with Acute Infections by PAYEN, S, SERREAU, R, MUNCK, A, AUJARD, Y, AIGRAIN, Y, BRESSOLLE, F, JACQZ-AIGRAIN, E

    Published in Antimicrobial Agents and Chemotherapy (01-10-2003)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  5. 5
  6. 6

    État des connaissances sur les contaminants dans le lait maternel by Serreau, R, Rigourd, V, Pommeret, B

    Published in Revue de médecine périnatale (01-09-2017)
    “…Une exposition anténatale est souvent à l'origine des effets indésirables des xénobiotiques. La femme allaitante et l'enfant allaité sont une population cible…”
    Get full text
    Journal Article
  7. 7

    Retrospective Diagnosis of an Adverse Drug Reaction in a Breastfed Neonate: Liquid Chromatography-Tandem Mass Spectrometry Quantification of Dextropropoxyphene and Norpropoxyphene in Newborn and Maternal Hair by Rigourd, V., Amirouche, A., Tasseau, A., Kintz, P., Serreau, R.

    Published in Journal of analytical toxicology (01-11-2008)
    “…Dextropropoxyphene (DP) and norpropoxyphene (NP) are commonly used in the treatment of postpartum pain. The drug is widely prescribed in Europe and Canada and…”
    Get full text
    Journal Article
  8. 8

    PP116. Circulating PlGF can help predict preeclampsia and adverse outcome in patients with suspected preeclampsia or fetal growth restriction by Sibiude, J, Dionne, M.-D, Guibourdenche, J, Le Ray, C, Anselem, O, Serreau, R, Goffinet, F, Tsatsaris, V

    Published in Pregnancy hypertension (01-07-2012)
    “…Introduction The circulating concentration of PlGF is reported to be lower in patients experiencing preeclampsia and patients delivering a small for…”
    Get full text
    Journal Article
  9. 9

    Immunohistochemical localisation and mRNA quantification of P-gp in human term placentas - no impact of corticosteroid administration for preterm labor by Serreau, R., Fakhoury, M., Bonihay, G., Medard, Y., Peuchmaur, M., Mokhdad, A., Oury, J., Jacqz‐Aigrain, E.

    Published in Clinical pharmacology and therapeutics (01-02-2004)
    “…P‐glycoprotein (P‐gp) is an energy‐dependent efflux pump expressed in the syncythiotrophoblast of human placenta throughout pregnancy, suggesting a potential…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Prise en charge en maternité des nouveau-nés à risque d’hypoglycémie — CoFAM by Bruel, H., de Villepin, B., Beziz, D., Marchalot, A., Foix-L’Hélias, L., Mitanchez, D., Serreau, R.

    Published in Revue de médecine périnatale (01-12-2013)
    “…Résumé: Afin de prévenir l’hypoglycémie néonatale, chez tous nouveau-nés, il est conseillé de lutter contre l’hypothermie (peau à peau avec les parents,…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Developmental toxicity of the angiotensin II type 1 receptor antagonists during human pregnancy: a report of 10 cases by Serreau, Raphael, Luton, Dominique, Macher, Marie‐Alice, Delezoide, Anne‐Lise, Garel, Catherine, Jacqz‐Aigrain, Evelyne

    “…Objective  Angiotensin II type 1 receptor antagonists (ARA). Interacted with the renin–angiotensin system, and the present study was undertaken to examine…”
    Get full text
    Journal Article
  14. 14

    CASE REPORT: Retrospective Diagnosis of an Adverse Drug Reaction in a Breastfed Neonate: Liquid Chromatography-Tandem Mass Spectrometry Quantification of Dextropropoxyphene and Norpropoxyphene in Newborn and Maternal Hair by Rigourd, V, Amirouche, A, Tasseau, A, Kintz, P, Serreau, R

    Published in Journal of analytical toxicology (01-12-2008)
    “…Dextropropoxyphene (DP) and norpropoxyphene (NP) are commonly used in the treatment of postpartum pain. The drug is widely prescribed in Europe and Canada and…”
    Get full text
    Journal Article
  15. 15

    Protocole d’administration de l’Uvestérol ADEC® au prématuré nourri au lait de femme enrichi by Rigourd, V., Dridi Brahim, I., Smii, S., Razafimahefa, H., Quetin, F., Leroy, E., Pichon, C., Giuseppi, A., Berthier, L., Pommeret, B., Serreau, R.

    “…Pour atteindre les recommandations nutritionnelles d’apports en protéines, énergie, vitamines et oligo-éléments chez le prématuré de moins de 2500g, le lait de…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Conseils pour l’allaitement maternel by Rigourd, V., Nicloux, M., Hovanishian, S., Giuséppi, A., Hachem, T., Assaf, Z., Pichon, C., Kermorvant, E., Serreau, R., Jacquemain, K., Panard, M., de Villepin, B., Lapillonne, A., Magny, J.-F.

    Published in Journal de pédiatrie et de puériculture (01-05-2018)
    “…Le lait maternel est unique sur le plan biologique et nutritionnel. Sa composition évolue constamment pour répondre au mieux aux besoins de l’enfant jusqu’à…”
    Get full text
    Journal Article
  18. 18

    Drugs during preeclampsia. Fetal risks and pharmacology by Serreau, R

    “…During pregnancy, the maternal, placental and fetal physiological characteristics constantly evolve and thereby constantly alter drug bioavailability in the…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Médicaments utilisés dans la prise en charge de la prééclampsie. Pharmacologie et risques fœtaux by Serreau, R.

    “…Pendant la grossesse, l’évolution des caractéristiques physiologiques maternelles, placentaires et fœtales modifient de façon constante la disponibilité des…”
    Get full text
    Journal Article